首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Bilateral Ovary Adrenal Rest Tumor in a Congenital Adrenal Hyperplasia Following Adrenalectomy
Institution:1. Department of Endocrinology;2. Department of Gynecology;3. Department of Pathology, Hôtel-Dieu de France University Hospital, Beirut, Lebanon.;1. Department of Endocrinology, University Hospital Complex, Albacete, Spain;2. Departments of Endocrinology and Molecular Genetics,;3. Clinical Genetics, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, United Kingdom.;1. Interdisziplinäre Endokrinologie, Diabetologie und Neurochirurgie, Universitätsklinikum Hamburg-Eppendorf,;2. Institut für Pathologie, Universitätsklinikum Hamburg-Eppendorf;3. Klinik und Poliklinik für Nuklearmedizin, Zentrum für Radiologie und Endoskopie, Hamburg, Germany.;1. University of Rochester Department of Medicine, Division of Endocrinology;2. University of Rochester Department of Pathology and Laboratory Medicine;3. University of Rochester Department of Obstetrics & Gynecology, Division of Maternal Fetal Medicine;4. University of Rochester Department of Surgical Oncology, Division of Endocrinology & Metabolism, University of Rochester Medical Center, Rochester, New York
Abstract:Objective:In contrast to the high incidence of testicular adrenal rest tumors in adult male patients with congenital adrenal hyperplasia (CAH), ovarian adrenal rest tumors (OARTs) in female CAH patients are rare. In this case report, we describe a case of bilateral OART in a female patient with CAH due to 21-hydroxylase deficiency.Methods:We present a detailed case report with the clinical, imaging, and laboratory findings of the patient. The pertinent literature is also reviewed.Results:A 17-year-old patient was known to have CAH due to 21-hydroxylase deficiency. Since the second month of her gestational age, her mother was treated with cortisone-replacement therapy. The patient was treated with hydrocortisone and fludrocortisone since the neonatal period. Her pertinent history included a bilateral adrenalectomy at the age of 13 years in 2006, and for 3 years she led a normal puberty life with no complaint with hormonal replacement therapy. Nevertheless, in 2009, she developed a virilizing syndrome. Subsequently, she underwent surgery in December 2009 for right adnexectomy. However, the regression of the masculinizing mass was not complete and worsened several months after the surgery. A new pelvic magnetic resonance image showed the activation of a contralateral ovarian mass, necessitating a left adnexectomy in August 2010.Conclusion:This case demonstrates some interesting features of OART that pose challenges to its management. If an OART is detected early enough and glucocorticoid therapy is received, it is possible that the OART will decrease in size following suppression of adrenocorticotropic hormone levels. (Endocr Pract. 2014;20:e69-e74)
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号